Clinical Perspectives in Head and Neck Cancer

Head and Neck Cancer: Emerging Perspectives

Volumn , Issue , 2003, Pages 3-8

  Ensley, John F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885347976     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012239990-9/50002-3     Document Type: Chapter

References (60)

1. Al-Sarraf M., Kish J.A., Ensley J.F. The Wayne State University experience with adjuvant chemotherapy of head and neck cancer. Hem/Oncol. Clin. North Am. 1991, 5(4):687-700.
2. Ensley J.F. Molecular Medicine, the forests, trees, and leaves. Arch. Otolaryngol. Head Neck Surg. 1993, 119:1173-1177.
3. de Braud F., Heilbrun L.K., Ahmed K., Sakr W., Ensley J., Kish J., Tapazoglou E., Al-Sarraf M. Squamous cell carcinoma of unknown primary metastatic to the neck: Advantages of an aggressive treatment. Cancer 1989, 64:510-515.
4. Ensley J.F., Kim H., Yoo G. Locally advanced nasopharyngeal carcinoma. Curr. Treat. Opin. Oncol. 2001, 2:15-23.
5. LoRusso P., Tapazoglou E., Kish J.A., Ensley J.F., Cummings G., Kelly J., Al-Sarraf M. Chemotherapy for paransal sinus carcinoma: A ten-year experience at Wayne State University. Cancer 1988, 62:1-5.
6. Kim E.S., Khuri F.R., Lee J.J., Winn R., Cooper J.M., Fu K., Lippman S.M., Vokes E.E., Pajak T.F., Goepfert H., Hong W.K. Second primary tumor incidence related primary index tumor and smoking status in a randomized chemoprevention study of head and neck squamous cell cacner. Proc. ASCO 2000, 19:1642. [Abstract].
7. Looser K.G., Shah J.P., Strong E.W., Salesiotis A.N., Cullen K.J. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978, 1:107-111.
8. Spiro R.H., DeRose G., Strong E.W. Cervical node metastasis of occult origin. Am. J. Surg. 1983, 146:441-446.
9. Ensley J., Crissman J., Kish J., Jacobs J., Weaver A., Kinzie J., Cummings G., Al-Sarraf M. The impact of morphological analysis on response rates and survival in patients with squamous cell cancer of the head and neck. Cancer 1986, 57:711-717.
10. Ensley J., Crissman J., Kish J., Weaver A., Jacobs J., Cummings G., Al-Sarraf M. The correlation of individual parameters of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction therapy. Cancer 1989, 63:1487-1492.
11. Sakr W., Hassan M., Zarbo R., Ensley J., Crissman J.D. DNA quantitation and histologic characteristics of squamous cell carcinomas of the upper aerodigestive tract. Arch. Pathol. Lab. Med. 1989, 113:1009-1014.
12. Laramore G.E., Scott C.B., Al-Sarraf M., Haselow R.E., Ervin T.J., Wheeler R., Jacobs J.R, Schuller D.E., Gahbauer R.A., Schwade J.G. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034. Int. J. Radiat. Oncol. Biol. Phys. 1992, 23:705-713.
13. Looser K.G., Shah J.P., Strong E.W. The significance of positive margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978, 1:107-111.
14. Hoffman H.T., Karnel L.H., Robinson R.A., Pinkston J.A., Menck H.R. National Cancer Data Base report on cancer of the head and neck: Acinic cell carcinoma. Head Neck 1999, 21:297-309.
15. Hicks M.J., el-Naggar A.K., Flaitz C.M., Luna M.A., Batsakis J.G. Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: A clinicopathologic and flow cytometric investigation. Head Neck 1995, 17:89-95.
16. Spiro R.H., Huvos A.G., Berk R., Strong E.W. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am. J. Surg. 1978, 136:461-468.
17. Spiro R.H., Huvos A.G., Strong E.W. Adenoid cystic carcinoma: Factors influencing survival. Am. J. Surg. 1979, 138:579-583.
18. Koch W.M., Brennan J.A., Zahurak M., Goodman S.N., Westra W.H., Schwab D., Yoo G.H., Lee D.J., Forastiere A.A., Sidransky D. p53 mutations and locoregional treatment failure in head and neck squamous cancer. J. Natl. Cancer Inst. 1996, 88:1580-1586.
19. Vanselow B., Eble M.J., Ruda V., Wollensack P., Conradt C., Dietz A. Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapy. Otolaryngol. Head Neck Surg. 2000, 122:856-862.
20. Shintani S., Mihara M., Nakahara Y., Terakado N., Yoshihama Y., Kiyota A., Ueyama Y., Matsumura T. Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas. Cancer Lett. 2000, 154:71-77.
21. Amer M.H., Al-Sarraf M., Vaitkevicius V.K. Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer 1979, 43:2202-2206.
22. Amer M.H., Izbick R.M., Vaitkevicius V.K., Al-Sarraf M. Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer: Phase II. Cancer 1980, 45:217-223.
23. Amer M.H., Izbick R.M., Vaitkevicius V.K., Al-Sarraf M. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancers. N. Engl. J. Med. 1991, 324:1685-1690.
24. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J. Natl. Cancer Inst. 1996, 88:890-899. EORTC Head and Neck Cancer Cooperative Group.
25. Rooney M., Kish J., Jacobs J., Kinzie J., Weaver A., Crissman J., Al-Sarraf M. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985, 55:1123-1128.
26. Al-Kourainy K., Kish J.A., Ensley J.F., Tapazoglou E., Jacobs J., Weaver A., Crissman J., Cummings G., Al-Sarraf M. Achievement of superior survival for histologically negative vs histologically positive clinically complete responders to cisplatinum combination in patients with locally advanced head and neck cancer. Cancer 1987, 59:233-238.
27. Ensley J., Jacobs J., Weaver A., Kinzie J., Al-Sarraf M. The correlation between response to cisplatinum combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984, 54:811-814.
28. Ensley J.F., Kish J.A., Jacobs J., Weaver A., Crissman J., Al-Sarraf M. Incremental improvements in median survival associated with degree of response to adjuvant chemotherapy in patients with advanced squamous cell cancer of the head and neck. Adjuvant Therapy of Cancer 1984, 117-126. Grune & Stratton. S.E. Jones, S.E. Salmon (Eds.).
29. Ensley J., Ahmad K., Kish J., Tapazoglou E., Al-Sarraf M. Salvage of patients with advanced squamous cell cancers of the head and neck (SCCHN) following induction chemotherapy failure using radiation and concurrent cisplatinum (CACP). Adjuvant Therapy of Cancer 1990, 92-100. Saunders, Orlando, FL. S.E. Salmon (Ed.).
30. Ensley J., Maciorowski M. Clinical application of DNA content parameters in patients with squamous cell carcinomas of the head and neck. Semin. Oncol. 1994, 21:330-339.
31. Ensley J.F. The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck. Cancer Metast. Res. 1996, 15:133-141.
32. Salesiotis A.N., Cullen K.J. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: Evolution of a model beyond TNM staging. Curr. Opin. Oncol. 2000, 12:229-239.
33. Chiesa F., Mauri S., Tradati N., Calabrese L., Giugliano G., Ansarin M., Andrle J., Zurrida S., Orecchia R., Scully C. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol. 1999, 35:590-596.
34. Liu M., Weynand B., Delos M., Marbaix E. Prognostic factors in squamous cell carcinomas of the head and neck. Cancer J. Sci. Am. 2000, 6:2-10.
35. Tralongo V., Rodolico V., Luciani A., Marra G., Daniele E. Prognostic factors in oral squamous cell carcinoma. A review of the literature. Anticancer Res. 1999, 19:3503-3510.
36. Chomchai J.S., Du W., Sarkar F.H., Li Y.W., Jacobs J.R., Ensley J.F., Sakr W., Yoo G.H. Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope 1999, 109:455-459.
37. Narayana A., Vaughan A.T., Kathuria S., Fisher S.G., Walter S.A., Reddy S.P. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:21-26.
38. Bradford C.R., Wolf G.T., Carey T.E., Zhu S., Beals T.F., Truelson J.M., McClatchey K.D., Fisher S.G. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma. Otolaryngol. Head Neck Surg. 1999, 121:534-538.
39. Hitchcock C., Zalupski M., Ensley J. Solid tumor preparative technology. Cytometry 2000. Flow Cytometric Analysis of Solid Tumors 1995, 95-124. Kluwer Academic, New York. A. Nakeff, F. Valeriote, J. Crissman, S. Lerman, J. Ensley (Eds.).
40. Ensley J.F., Maciorowski Z., Pietraszkiewicz H., Klemic G., KuKuruga M., Sapareto S., Corbett T., Crissman J.D. Solid tumor preparation for flow cytometry using a standard murine tumor model. Cytometry 1989, 8:479-487.
41. Ensley J., Maciorowski Z., Hassan M., Pietraszkiewicz H., Sakr W., Hielbrun L. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry. Cytometry 1993, 14:550-558.
42. Kage T., Mogi M., Katsumata Y., Chino T. Regional lymph node metastasis created by partial excision of carcinomas induced in hamster cheek pouch with 9,10-dimethyl-1,2-benzanthracene. J. Dent. Res. 1987, 66:1673-1679.
43. Hawkins B.L., Heniford B.W., Ackermann D.M., Leonberger M., Martinez S.A., Hendler F.J. 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma. Head Neck 1994, 16:424-432.
44. Hier M.P., Black M.J., Shenouda G., Sadeghi N., Karp S.E. A murine model for the immunotherapy of head and neck squamous cell carcinoma. Laryngoscope 1995, 10:1077-1080.
45. Sung M.W., Lee S.G., Yoon S.J., Lee H.J., Heo D.S., Kim K.H., Koh T.Y., Choi S.H., Park S.W., Koo J.W., Kwon T.Y. Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model. Anticancer Res. 2000, 20(3A):1653.
46. Cardinalli M., Pietraszkiewicz H., Ensley J.F., Robbins K.C. Tyrosine phosphorylation as a marker for aberrantly regulated growth promoting pathways in cells derived from head and neck malignancies. Int. J. Cancer 1995, 61:98-103.
47. Shridhar R., Shridhar V., Rivard S., Siegfried J.M., Pietraszkiewicz H., Ensley J.F., Pauley R., Grignon D., Sakr W., Miller O.J., Smith D.I. Mutations in the arginine-rich protein (ARP) gene in lung, breast prostate cancers and in squamous cell carcinomas of the head and neck. Cancer Res. 1997, 56:5576-5578.
48. Park N.H., Gujuluva C.N., Baek J.H., Cherrick H.M., Shin K.H., Min B.M. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: An in vitro multistep carcinogenesis model. Oncogene 1995, 10:2145-2153.
49. Eicher S.A., Clayman G.L., Liu T.J., Shillitoe E.J., Storthz K.A., Roth J.A., Lotan R. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin. Cancer. Res. 1996, 10:1659-1666.
50. Yeudall W.A., Jakus J., Ensley J., Robbins K.C. Functional characterization of p53 molecules expressed in human squamous cell carcinomas. Mol. Carcinogen. 1997, 18:89-96.
51. Cardinali M., Kartochvil J., Ensley J.F., Robbins K.C., Yeudall W.A. Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck. Mol. Carcinogen. 1997, 18:78-88.
52. Gardner D.G. Spontaneous squamous cell carcinomas of the oral region in domestic animals: A review and consideration of their relevance to human research. Oral Dis. 1996, 2:148-154.
53. Hamburger A.W., Salmon S.E. Primary bioassay of human tumor stem cells. Science 1977, 197:461-463.
54. Chabner B.A., Boral A.L., Multani P. Translational research: walking the bridge between idea and cure-seventeenth Bruce F. Cain Memorial Award lecture. Cancer Res. 1998, 58:4211-4216.
55. Bartelink H., Begg A.C., Martin J.C., van Dijk M., Moonen L., van't Veer L.J., Van de Vaart P., Verheij M. Translational research offers individually tailored treatments for cancer patients. Cancer J. Sci. Am. 2000, 6:2-10.
56. Krause R.M. The beginning of health is to know the disease. Public Health Rep. 1983, 98:531-535.
57. Rhodes P. Research. Br. Med. J. (Clin. Res. Ed.) 1983, 286:1271-1272.
58. Medawar S.P. Scientific method in science and medicine. Perspect. Biol. Med. 1975, 18:345-352.
59. Potter V.R. On the road to the blocked ontogeny theory. Adv. Oncol. 1988, 4:43-46.
60. Potter V.R. Blocked ontogeny. Science 1987, 237(4818):964.